STOCK TITAN

Uxin Ltd. (UXIN) Financials

UXIN
FY2025 annual
Revenue $463.3M +143.3% YoY
Net Income -$37.5M +27.2% YoY
EPS (Diluted) $0.00 +100.0% YoY
Free Cash Flow -$75.2M -97.3% YoY
Market Cap $246.4M as of Sep 3, 2026
Price / Sales 0.5x on $463.3M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UXIN SEC filings page.

Uxin Ltd. (UXIN) reported $463.3M in revenue for fiscal year 2025, up 143.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI UXIN FY2025

Uxin's reported rebound is driven by scale and cost cuts, but inventory absorption and financing still dominate cash economics.

The rebound did not translate into cash: inventory expanded from $15.3M to $78.0M. That working-capital build helps explain why operating cash flow deteriorated to -$72.1M from -$36.3M despite improved margins.

FY2025 gross margin reached 6.7%, while operating margin was still -5.4%; the improvement points more to cost absorption than a proven price effect. SG&A fell to $12.8M, helping explain the sharper operating improvement.

Net loss of -$37.5M exceeded operating loss of -$24.8M, showing financing costs still dilute operating gains. Negative equity of -$33.0M alongside liabilities of $330.8M, plus financing cash flow of $83.2M, indicates reliance on external capital while the current ratio remained only 0.8x.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 24 / 100
Financial Health Score 24/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Uxin Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
29

Uxin Ltd. has an operating margin of -5.4%, meaning the company loses $5 on every $100 of revenue. This results in a profitability score of 29/100. This is up from -22.7% the prior year.

Growth
86

Uxin Ltd.'s revenue surged 143.3% year-over-year to $463.3M, reflecting rapid business expansion. This strong growth earns a score of 86/100.

Leverage
0

Not available for Uxin Ltd., and counted as zero in the overall score.

Liquidity
10

Uxin Ltd.'s current ratio of 0.76 is below the typical benchmark, resulting in a score of 10/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
9

Uxin Ltd.'s operations used $72.1M of cash, and capex of $3.1M added to the outflow, for a free cash flow shortfall of $75.2M. This results in a cash flow score of 9/100.

Returns
12
Altman Z-Score Distress
-10.06

Uxin Ltd. scores -10.06, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($246.4M) relative to total liabilities ($330.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/7

Uxin Ltd. passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Uxin Ltd. reported a net loss of $37.5M while operations used $72.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Uxin Ltd. reported an operating loss of $24.8M against $13.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$11.9M
YoY+245.1%
QoQ+24.6%

Uxin Ltd. held $11.9M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

UXIN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UXIN quarterly income statement
MetricQ4'2520-FQ2'256-KQ4'2410-KQ1'2410-KQ1'2310-KQ1'2210-KQ3'2110-QQ1'2110-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

UXIN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UXIN quarterly balance sheet
MetricQ4'2520-FQ2'256-KQ4'2410-KQ1'2410-KQ1'2310-KQ1'2210-KQ3'2110-QQ1'2110-K
Total Assets$345.9M+29.3%$285.3M$267.4M$289.2M+176.4%$104.6M-47.0%$197.4M+4.8%$205.9M$188.3M-49.6%
Current Assets$106.4M+128.8%$62.5M$46.5M$31.4M-23.6%$41.0M-70.3%$137.9M+8.5%$146.1M$127.1M-59.8%
Cash & Equivalents$11.9M+245.1%$9.5M$3.4M$3.2M-76.1%$13.5M-33.2%$20.2M-31.3%$33.6M$29.4M-39.2%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$78.0M+174.6%$39.0M$28.4M$15.3M-5.2%$16.1M-76.0%$67.2M+533.1%$45.3M$10.6M+628.5%
Accounts Receivable$660K+16.0%$502K$569K$289K+151.3%$115K-12.2%$131K-65.1%$515K$375K-58.5%
Long-Term Investments$0$0$0$38.7M-8.0%$42.0M-7.7%$45.5M+3.5%$44.8M$44.0M+12.6%
Total Liabilities$330.8M+11.5%$282.6M$296.6M$309.0M+6.5%$290.0M-33.4%$435.6M-11.6%$707.6M$492.9M-30.1%
Current Liabilities$139.7M+33.8%$90.7M$104.4M$122.6M+39.4%$87.9M-57.1%$204.9M+17.0%$485.7M$175.1M-59.7%
Non-Current Liabilities$191.1M-0.6%$191.9M$192.2M$186.4M+84.9%$100.8M-31.7%$147.7M-53.5%$221.9M$317.8M+17.5%
Long-Term DebtN/AN/A$7.4MN/A$42.5MN/A$36.2MN/A
Total Equity-$33.0M+34.5%-$39.8M-$50.4M-$40.6M+78.1%-$185.4M+22.2%-$238.2M+21.8%-$501.7M-$304.6M+8.0%
Retained Earnings-$2.8B-5.9%-$2.8B-$2.7B-$2.7B-8.8%-$2.5B+2.6%-$2.5B-4.3%-$2.7B-$2.4B-11.0%

Not reported in any period shown, so not listed: Goodwill.

UXIN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UXIN quarterly cash flow statement
MetricQ4'2520-FQ2'256-KQ4'2410-KQ1'2410-KQ1'2310-KQ1'2210-KQ3'2110-QQ1'2110-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

UXIN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UXIN quarterly financial ratios
MetricQ4'2520-FQ2'256-KQ4'2410-KQ1'2410-KQ1'2310-KQ1'2210-KQ3'2110-QQ1'2110-K
Current Ratio0.76+0.3x0.690.450.26-0.2x0.47-0.2x0.67-0.1x0.300.730.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$33.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Uxin Ltd. UXIN FY2025 $463.3M -$37.5M -8.1% $246.4M 24/100
Camping World CWH FY2025 $6.4B -$105.6M -1.7% $433.4M 29/100
Kingsway Finl KFS FY2025 $135.0M -$10K 0.0% $307.2M 26/100
Acv Auctions Inc. ACVA FY2025 $759.6M -$66.1M -8.7% $1.1B 48/100
Mister Car Wash Inc MCW FY2025 $1.1B $103.1M 9.8% $2.3B 38/100
SunCar Technology Group Inc. SDA FY2024 $441.9M -$64.5M -14.6% $67.4M 30/100

Frequently Asked Questions

What is Uxin Ltd.'s annual revenue?

Uxin Ltd. (UXIN) reported $463.3M in total revenue for fiscal year 2025. This represents a 143.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Uxin Ltd.'s revenue growing?

Uxin Ltd. (UXIN) revenue grew by 143.3% year-over-year, from $190.4M to $463.3M in fiscal year 2025.

Is Uxin Ltd. profitable?

No, Uxin Ltd. (UXIN) reported a net income of -$37.5M in fiscal year 2025, with a net profit margin of -8.1%.

Uxin Ltd. (UXIN) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Uxin Ltd. (UXIN) had EBITDA of -$15.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Uxin Ltd. (UXIN) had a gross margin of 6.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Uxin Ltd. (UXIN) had an operating margin of -5.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Uxin Ltd. (UXIN) had a net profit margin of -8.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Uxin Ltd. (UXIN) recorded an outflow of $75.2M in free cash flow during fiscal year 2025. This represents a -97.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Uxin Ltd. (UXIN) recorded an outflow of $72.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Uxin Ltd. (UXIN) had $345.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Uxin Ltd. (UXIN) invested $3.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Uxin Ltd. (UXIN) invested $1.8M in research and development during fiscal year 2025.

Uxin Ltd. (UXIN) had a current ratio of 0.76 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Uxin Ltd. (UXIN) had a return on assets of -10.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Uxin Ltd. (UXIN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $246.4M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Uxin Ltd. (UXIN) trades at 0.5x sales, its market capitalization divided by revenue of $463.3M revenue, FY2025. The market capitalization is $246.4M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Uxin Ltd. (UXIN) held $11.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $72.1M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Uxin Ltd. (UXIN) has negative shareholder equity of -$33.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Uxin Ltd. (UXIN) has an Altman Z-Score of -10.06, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Uxin Ltd. (UXIN) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Uxin Ltd. (UXIN) reported a net loss of $37.5M while operations used $72.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Uxin Ltd. (UXIN) reported an operating loss of $24.8M against $13.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Uxin Ltd. (UXIN) scores 24 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top